rs561367199
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000048.4(ASL):โc.332G>Aโ(p.Arg111Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,630 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (โ โ ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R111W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000048.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASL | NM_000048.4 | c.332G>A | p.Arg111Gln | missense_variant | 5/17 | ENST00000304874.14 | NP_000039.2 | |
ASL | NM_001024943.2 | c.332G>A | p.Arg111Gln | missense_variant | 4/16 | NP_001020114.1 | ||
ASL | NM_001024944.2 | c.332G>A | p.Arg111Gln | missense_variant | 4/15 | NP_001020115.1 | ||
ASL | NM_001024946.2 | c.332G>A | p.Arg111Gln | missense_variant | 4/15 | NP_001020117.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASL | ENST00000304874.14 | c.332G>A | p.Arg111Gln | missense_variant | 5/17 | 1 | NM_000048.4 | ENSP00000307188.9 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000600 AC: 15AN: 250184Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135564
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461464Hom.: 1 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727028
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74404
ClinVar
Submissions by phenotype
Argininosuccinate lyase deficiency Pathogenic:6Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 18, 2024 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Laboratory Sciences Program (CLSP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) | Apr 01, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | research | Al Jalila Childrenโs Genomics Center, Al Jalila Childrens Speciality Hospital | Oct 04, 2024 | PM5,PM2,PM3(moderate),PP1,PM1,PP3 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 25, 2024 | - - |
Uncertain significance, flagged submission | clinical testing | Counsyl | Aug 23, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 111 of the ASL protein (p.Arg111Gln). This variant is present in population databases (rs561367199, gnomAD 0.04%). This missense change has been observed in individual(s) with argininosuccinate lyase deficiency (PMID: 24516753; Invitae). ClinVar contains an entry for this variant (Variation ID: 288770). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ASL protein function with a positive predictive value of 95%. This variant disrupts the p.Arg111 amino acid residue in ASL. Other variant(s) that disrupt this residue have been observed in individuals with ASL-related conditions (PMID: 1705937), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 02, 2023 | Variant summary: ASL c.332G>A (p.Arg111Gln) results in a conservative amino acid change located in the Fumarate lyase, N-terminal domain (IPR022761) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6e-05 in 250184 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in ASL causing Argininosuccinic Aciduria (6e-05 vs 0.0042), allowing no conclusion about variant significance. c.332G>A has been reported in the literature in multiple homozygous individuals affected with Argininosuccinic Aciduria (e.g., Al-Shamsi_2014, Al-Jasmi_2016, Saleh_2021). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26589311, 24516753, 34374989). Four submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. Multiple submitters reported the variant with conflicting assessments (pathogenic, n = 1; likely pathogenic, n = 1; uncertain significance, n = 2). Additionally, a different missense variant disrupting the same codon, c.331C>T (p.Arg111Trp), has been reported in patients with Argininosuccinic Aciduria (PMIDs: 1705937, 31737040, 33611823) and classified as likely pathogenic by our lab. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1Uncertain:1
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | Jun 30, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 15, 2016 | The R111Q variant has been published in a patient with argininosuccinic aciduria who was homozygous for R111Q and who was diagnosed following an abnormal newborn screening result (Al-Shamsi et al. 2014). The R111Q variant was not observed with any significant frequency in either the 1000 Genomes Project Consortium or in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The R111Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at